• 

  Could Alzheimer’s Drugs Work Better in Pairs? A New Approach for ‘Mabs’
• 

  Gene Therapy ‘First’: Huntington’s Disease Treated in Early Trial
• 

  Australia Drug Regulators Approve Leqembi for Alzheimer’s
• 

  Bridging the Diversity Gap: Why Alzheimer’s Research in Africa Matters
• 

  How a Brainwave Test Can Help Foretell Alzheimer’s in Just 3 Minutes
• 

  Lewy Body Dementia Treatment: What Helps Now, and What’s in Clinical Trials
• 

  Inside Look: How Doctors Diagnose Lewy Body Dementia
• 

  Menopause, Hormone Therapy, and Alzheimer’s: Why HRT Timing Matters
• 

  France, UK Insurers Say They Won’t Cover Alzheimer’s Drug Leqembi
• 

  Lewy Body Dementia: Symptoms, Causes, Risk Factors, and Diagnosis
• 

  FDA Approved: An Injectable Version of Alzheimer’s Drug Leqembi
• 

  Babies Have Higher Levels of This Alzheimer’s Biomarker
• 

  Digital Cognitive Tests: How AI Tools Could Transform Alzheimer’s Diagnosis and Care
• 

  Cold Sore Virus Concept for Alzheimer’s Takes a Hit in Drug Trials
• 

  Tidal Change: China Takes Alzheimer’s ‘Seaweed Drug’ Off the Market

Previous456Next